Research Grade Felvizumab

• Description:

  Felvizumab[HuRSV19VHFNS/VK, RSHZ19, RSVmonoclonalantibody, SB209763]isahumanisedmonoclonalantibody (IgG1) preparedbythehumanizationofanFprotein-specificmurineMAb.Ininvitrostudies, palivizumab, anotherhumanizedMabspecificfortheFproteinofRSV, was4to5-foldmorepotentthanfelvizumabinneutralisingRSV (Scott, 1999) .RSHZ19 (Felvizumab) RSVThisantibodywas

• Product Name Alternative:

  SB209763, HuRSV19VHFNS/VK, RSHZ19monoclonalantibody, SB209763, CAS:167747-20-8

• Expression System:

  Mammalian Cells

• Host:

  Humanized

• Target:

  F, FusionglycoproteinF0, FusionglycoproteinF2, p27, Interveningsegment, Pep27, Peptide27, FusionglycoproteinF1

• Clonality:

  Monoclonal

• Applications:

  ELISA, Bioactivity: FACS, Functional assay, Research in vivo

• Purification:

  Protein A/G purified from cell culture supernatant.

• Concentration:

  1 mg/mL

• Purity:

  > 95% as determined by SDS-PAGE.

• Form:

  Liquid

• Buffer:

  0.01M PBS, pH7.4.

• Storage Conditions:

  Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at4°C short term (1-2weeks) . Store at-20°C 12 months. Store at -592°C long term.

• Notes:

  For research use only. Not suitable for clinical or therapeutic use.

• Species:

  HRSV-A